arrow
H

Haris I. Sair

Johns Hopkins University School of Medicine
H指数:37
被引数:4,677

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GUARD-LGG: a glioma upfront AI-driven radiotherapy response decipher for lower-grade glioma

GUARD-LGG: 针对低级别神经胶质瘤的神经胶质瘤前期AI驱动的放射治疗反应破译

2026-10-200
OAAI
EXPANDED PERIVASCULAR SPACE AS A POTENTIAL RADIOLOGIC SIGN OF TREATMENT RESPONSE IN IDH-MUTATED GLIOMA TREATED WITH IDH-INHIBITORS - A RADIOMICS STUDY

血管周围间隙扩大作为IDH突变型胶质瘤经IDH抑制剂治疗后反应的潜在放射学标志物——一项放射组学研究

2025-11-010
OAAI
Imaging the distribution and drainage of fluid in the human olfactory regions using intravenous Gadolinium-based contrast agents (GBCA) enhanced MRI

使用静脉注射钆基对比剂(GBCA)增强的MRI成像技术,观察人类嗅觉区域的液体分布和引流情况。

2025-10-160
OAAI
Impact of upfront adjuvant chemoradiation on survival in patients with molecularly defined oligodendroglioma: the benefits of PCV over TMZ

预先辅助放化疗对分子定义的少突胶质细胞瘤患者生存的影响: PCV优于TMZ的益处

2024-10-091
PRE
Genomic Alterations in Molecularly Defined Oligodendrogliomas
2024-07-152
PRE
Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in differentiating between brain tumor progression versus pseudoprogression and radionecrosis (vol 166, pg 1, 2024)
2024-06-100
OA
Assessing the Performance of Artificial Intelligence Models: Insights from the American Society of Functional Neuroradiology Artificial Intelligence Competition
2024-04-251
PRE
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling
STROKE
IF8.9
2024-01-011
PRE
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome
STROKE
IF8.9
2024-01-014
PRE